Healthcare Innovation Surge: Nearly $1 Billion Poured into Startups This Week

This week, we witnessed a robust influx of capital into the healthcare sector, with various companies securing significant funding across various stages and specialties.

From biotech firms developing cutting-edge therapies to health tech startups revolutionizing patient care, investors demonstrated strong confidence in healthcare innovation.

Notable rounds included Aktis Oncology's impressive $175 million Series B for targeted radiopharmaceuticals, Zing Health's $140 million raise for Medicare Advantage plans, and several other multimillion-dollar investments in areas such as AI diagnostics, gene therapies, and medical devices.

The reported funding totaled nearly $943 million, showcasing the continued momentum in healthcare investment despite broader economic uncertainties.

Top Deals

• Asabys Partners : €180 million new venture capital fund for life sciences.
• Aktis Oncology : $175 million for targeted alpha radiopharmaceuticals for solid tumors.
• Zing Health : $140 million for Medicare Advantage insurance.
• Centivo : $75 million for making healthcare more affordable.
• Several Deals: $50-$73 million raised by companies like Mendaera, Inc. (robotic interventions), Qure.ai (healthcare AI), Constructive Bio (synthetic genomics), and Route 92 Medical (neurovascular interventions).

See the full list of fundings: https://open.substack.com/pub/twidh/p/this-weeks-healthcare-funding-943m